Skip to main content

Table 3 Patients with CNS metastases

From: Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population

  LX TBP
Patients (N = 24) (N = 34)
Number of brain metastatic sites
  < 3 21(87.5%) 30(88.2%)
  ≥ 3 3(12.5%) 4(11.8%)
Local treatment
 Radiotherapy (WBRT and/or SRS) 19(79.2%) 28(82.4%)
 Neurosurgery with WBRT and/or SRS 5(20.8%) 6(17.6%)